Ziming Du
Ziming Du
Brigham and Women's Hospital, Harvard Medical School
Verified email at BICS.BWH.HARVARD.EDU
Cited by
Cited by
miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast CancermiR-125b Suppresses Breast Cancer Formation
Y Zhang, LX Yan, QN Wu, ZM Du, J Chen, DZ Liao, MY Huang, JH Hou, ...
Cancer research 71 (10), 3552-3562, 2011
Eight-signature classifier for prediction of nasopharyngeal carcinoma survival
HY Wang, BY Sun, ZH Zhu, ET Chang, KF To, JSG Hwang, H Jiang, ...
Journal of clinical oncology 29 (34), 4516-4525, 2011
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Z Du, M Abedalthagafi, AA Aizer, AR McHenry, HH Sun, MA Bray, ...
Oncotarget 6 (7), 4704, 2015
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A
ZM Du, LF Hu, HY Wang, LX Yan, YX Zeng, JY Shao, I Ernberg
PloS one 6 (4), e19137, 2011
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
Y Mei, WL Bi, NF Greenwald, Z Du, NYR Agar, UB Kaiser, ...
Oncotarget 7 (47), 76565, 2016
Upregulation of caveolin‐1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients
ZM Du, CF Hu, Q Shao, MY Huang, CW Kou, XF Zhu, YX Zeng, JY Shao
International journal of cancer 125 (8), 1832-1841, 2009
Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in …
J Li, HY Mo, G Xiong, L Zhang, J He, ZF Huang, ZW Liu, QY Chen, ZM Du, ...
Journal of Biological Chemistry 287 (42), 35484-35495, 2012
ARID1A and TERT promoter mutations in dedifferentiated meningioma
MS Abedalthagafi, WL Bi, PH Merrill, WJ Gibson, MF Rose, Z Du, ...
Cancer genetics 208 (6), 345-350, 2015
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
J Tang, R Deng, RZ Luo, GP Shen, MY Cai, ZM Du, S Jiang, MT Yang, ...
Breast cancer research and treatment 134 (2), 549-560, 2012
Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging
Z Du, JR Lin, R Rashid, Z Maliga, S Wang, JC Aster, B Izar, PK Sorger, ...
Nature protocols 14 (10), 2900-2930, 2019
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
S Coy, R Rashid, JR Lin, Z Du, AM Donson, TC Hankinson, NK Foreman, ...
Neuro-oncology 20 (8), 1101-1112, 2018
Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma
SM Yan, JJ Tang, CY Huang, SY Xi, MY Huang, JZ Liang, YX Jiang, YH Li, ...
PloS one 8 (2), e56366, 2013
Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade
IF Dunn, Z Du, M Touat, MB Sisti, PY Wen, R Umeton, AM Dubuc, ...
JCO precision oncology 2, 2018
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer
R Rashid, G Gaglia, YA Chen, JR Lin, Z Du, Z Maliga, D Schapiro, C Yapp, ...
Scientific data 6 (1), 1-10, 2019
Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours
MS Abedalthagafi, MP Wu, PH Merrill, Z Du, T Woo, SH Sheu, S Hurwitz, ...
The Journal of pathology 238 (4), 584-597, 2016
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma
I Nawaz, LF Hu, ZM Du, K Moumad, I Ignatyev, TV Pavlova, V Kashuba, ...
Oncotarget 6 (31), 31493, 2015
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
Y Mei, Z Du, C Hu, NF Greenwald, M Abedalthagafi, NYR Agar, GP Dunn, ...
Cell communication and signaling 15 (1), 1-11, 2017
Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1
ML Hemming, MJ Nathenson, JR Lin, S Mei, Z Du, K Malik, ...
JCO precision oncology 4, 2020
Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2
YX Jiang, ZM Du, L Jiao, Q Shao, S Fu, JY Shao, XF Zhu, I Ernberg, YH Li
International journal of clinical and experimental medicine 8 (6), 8472, 2015
Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results
WL Bi, L Nayak, DM Meredith, J Driver, Z Du, S Hoffman, Y Li, EQ Lee, ...
Neuro-oncology 24 (1), 101-113, 2022
The system can't perform the operation now. Try again later.
Articles 1–20